CONCORD, Calif.--(BUSINESS WIRE)--Feb. 12, 2009--
Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter
and year end 2008 financial results will be released on Thursday,
February 26, 2009, and that it will host a conference call and live
webcast at 4:30 p.m. EDT that afternoon. Management will discuss the
company's financial results and provide an overview of the company at
that time.
To access the webcast, log on to the Investor Relations page of the
Cerus Web site at www.cerus.com.
Alternatively, you may access the live conference call by dialing
877-407-0782 (U.S.) or 201-689-8567 (International). A telephone and
webcast replay will be available approximately two hours after the call
through March 5, 2009. The replay can be accessed by dialing
877-660-6853 (U.S.) or 201-612-7415 (International), and entering
account number 286 and conference ID number 285647. The webcast will be
archived on www.cerus.com.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused on
commercializing the INTERCEPT Blood System to enhance blood safety. The
INTERCEPT Blood System is designed to inactivate blood-borne pathogens
in donated blood components intended for transfusion. Cerus currently
markets the INTERCEPT Blood System for both platelets and plasma in
Europe, Russia, the Middle East and selected countries in other regions
around the world. The Company is also pursuing regulatory approvals in
the United States and other countries. The INTERCEPT red blood cell
system is currently in clinical development.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
Source: Cerus Corporation
Cerus Corporation
William J. Dawson, 925-288-6053
Vice
President, Finance & CFO